Redeye is positive about the results from CLS’s study at Skåne University Hospital. The study shows that LITT was safe and feasible, and that median survival exceeded that of the control group treated with open surgery. These results represent a step forward toward CE marking of the Prism system, which we expect during 2026e.
LÄS MER
